NSW is building an RNA drug development lab to commercialise university medical research

NSW is making a play to be at the cutting edge of drug and vaccine development with a new university-based lab and pre-clinical trial space to create early-stage mRNA and RNA-based drugs.

mRNA is the new science behind the Pfizer and Moderna Covid vaccines. While Australia has played a key role in research and development of vaccines in response to the global pandemic, it does not produce mRNA vaccines. The nation currently imports all its mRNA vaccines and is ceasing local production of the Astra Zeneca jab as global attention turns to RNA responses.

Premier Dominic Perrottet said the state government’s $96 million in funding for the facility is designed to attract commercial investment in local mRNA and RNA production.

“We are the first state in Australia to deliver a pilot manufacturing facility to spearhead the establishment of a local RNA industry,” he said.

Read Full Content Here […]

The domain name:  Actionize.com is available for purchase. Learn how you can use this domain for your business.

Learn More